To start off the New Year, this week's #FridayRead is from a lab close to our hearts. In collaboration with Qkine the team in Alessandro Bertero’s lab at the University of Turin have developed optimized media for the maintenance of human induced pluripotent stem cells (hiPSCs).
This recent publication in collaboration with Qkine focusses on the optimization of home-brew media for the maintenance of human induced pluripotent stem cells (hiPSCs), using Qkine growth factors to allow cost-effective, practical, and reproducible culture of hiPSCs. Qkine thermostable tag-free FGF2-G3 proteins were found to be highly bioactive, necessitating an 8-fold reduction in concentration for the short (145 aa) form of FGF2-G3 in the optimized media.
Hematopoietic stem cells (HSCs) are at the forefront of a transformative shift in modern medicine, beginning to revolutionize patient care by offering novel therapeutic treatments for a wide range of diseases. This review blog summarizes advances in the clinical use of HSCs in HSC transplantation.
Qkine is a company run by scientists, and the science is the focus of everything we do.Our theme at ISSCR this year was stress-free stem cell culture - exploring how suppliers of recombinant proteins can proactively improve the quality, availability and functionality of growth factors to generate experimental outcomes faster, easier and more efficiently.We discussed priorities for the stem cell science supply chain with scientists from academic and industry labs and had in-depth conversations about the impact of growth factors and cytokines quality on reproducibility and how to integrate new technologies, such as controlled-release and thermostable proteins, to improve the scalability of expansion and differentiation protocols.Through collaboration, we learn and, together, improve the future of stem cell research.
Reflections on the dynamic ISSCR 2024 workshop on Standards for Human Stem Cell Use in Research including recommendations for growth factor supply chains for raw (ancillary materials) for cell therapy and ATMP manufacture.
Specialist bioactive growth factor protein manufacturer Qkine today announced a new partnership with StemCultures, a life sciences company dedicated to developing innovative reagents that enhance the quality and efficiency of cell growth and differentiation in culture.
Qkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus
This month: Bovine/porcine FGF-2 out now, Qkine scale up manufacturing, why you should check vial recovery as part of your QC, and our latest blog article on our internship.
This month: download our latest poster on human pluripotent stem cell-directed differentiation, read a recent review article on human organoids and visit us in person at one of our upcoming events
This month: free growth factors for summer projects, GDNF, mLIF vs ESGRO and our new blog, the difference between growth factors and cytokines
© 2024 Qkine Ltd. Company number 10470662 registered in England and Wales. All rights reserved
